Screening for H. pylori in patients at high risk of gastric cancer appears to be cost saving in the USA
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - September 1, 2021 Category: Drugs & Pharmacology Source Type: news
H. Pylori May Hinder Efficacy of Immune Checkpoint Inhibitors H. Pylori May Hinder Efficacy of Immune Checkpoint Inhibitors
Helicobacter pylori decreased the efficacy of immune checkpoint inhibitors in mice and was associated with a less efficacious response to therapy in a retrospective study of nonsmall-cell lung cancer patients, researchers say.Reuters Health Information (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - July 29, 2021 Category: Gastroenterology Tags: Hematology-Oncology News Source Type: news
First-Line H pylori Regimens Ranked by Comparative Effectiveness First-Line H pylori Regimens Ranked by Comparative Effectiveness
A network meta-analysis found levofloxacin-containing therapy to be the best overall against Helicobacter pylori infection.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - July 12, 2021 Category: Gastroenterology Tags: Gastroenterology News Source Type: news
H. pylori: High Eradication, Fewer Side Events With Hybrid Therapy H. pylori: High Eradication, Fewer Side Events With Hybrid Therapy
A 14-day course of hybrid therapy was as effective as 10-day bismuth quadruple therapy, but with fewer side effects, according to results of a randomized trial.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - May 28, 2021 Category: Gastroenterology Tags: Gastroenterology News Source Type: news
H. pylori: High Eradication, Fewer Side Effects With Hybrid Therapy H. pylori: High Eradication, Fewer Side Effects With Hybrid Therapy
A 14-day course of hybrid therapy was as effective as 10-day bismuth quadruple therapy, but with fewer side effects, according to results of a randomized trial.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - May 28, 2021 Category: Gastroenterology Tags: Gastroenterology News Source Type: news
Cholestenone shows antibiotic properties against H. pylori
(Shinshu University) Helicobacter pylori, a gram-negative pathogen that has infected half of the world's population is a Group I carcinogen according to the WHO. H. pylori resides in the gastric mucosa causing gastritis, ulcers, gastric cancers and gastric malignant lymphoma. It can be eradicated in most infected people using a combination of three drugs including antibiotics clarithromycin. However drug-resistant H. Pylori is a growing problem and it is expected to develop drugs that exhibit anti-H. pylori activity. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 27, 2021 Category: International Medicine & Public Health Source Type: news
Practice Update: Eradication Strategies for H. pylori Infection Practice Update: Eradication Strategies for H. pylori Infection
Before switching antibiotics in patients with H pylori, clinicians should screen for factors such as nonadherence or inadequate suppression of gastric acid, according to a clinical practice update.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - April 23, 2021 Category: Gastroenterology Tags: Gastroenterology News Source Type: news
Predicting Gastric Cancer Risk After H. Pylori Eradication Predicting Gastric Cancer Risk After H. Pylori Eradication
This study evaluated the performance of seven different machine learning models in predicting gastric cancer risk after H. pylori eradication. Which was most accurate?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 14, 2021 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
Empirical bismuth-based quadruple therapy for H. pylori eradication: effective, less costly
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2021 Category: Drugs & Pharmacology Source Type: news
A novel approach to determine how carcinogenic bacteria find their targets
(Texas A&M University) The gram-negative bacteria Helicobacter pylori (H. pylori) colonize the stomachs of the majority of the world's population. Although most people may never experience major complications due to the pathogen, H. pylori infections increase the risk of certain types of gastric cancer, as well as other illnesses such as peptic ulcers and gastritis. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 10, 2021 Category: Cancer & Oncology Source Type: news
What Are the First Symptoms of H. pylori
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - February 9, 2021 Category: General Medicine Source Type: news
Regular walnut consumption may reduce negative outcomes of H. pylori infection
(Edelman Public Relations, Seattle) A new animal study, published in theJournal of Clinical Biochemistry and Nutrition, suggests regular walnut consumption may be a promising intervention for reducing negative outcomes associated with Helicobacter pylori (H. pylori) infection, a widespread bacterial infection that affects more than half of the world's population. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 9, 2021 Category: Infectious Diseases Source Type: news
Registry Reveals H. pylori Management Mistakes Registry Reveals H. pylori Management Mistakes
' [E]ven after more than 30 years of experience in H. pylori treatment, the ideal regimen to treat this infection remains undefined, ' the investigators wrote.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 26, 2021 Category: Consumer Health News Tags: Gastroenterology News Source Type: news
Carcinogens concepts receive input from NTP advisers
National Toxicology Program advisers gave scientific input on the bacteria <em>Helicobacter pylori</em>, and certain water disinfection by-products. (read more) (Source: Environmental Factor - NIEHS Newsletter)
Source: Environmental Factor - NIEHS Newsletter - January 6, 2021 Category: Environmental Health Source Type: news
Endoscopy cost effective for gastric cancer screening after H. pylori eradication
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - January 1, 2021 Category: Drugs & Pharmacology Source Type: news
